Search research articles
Contact Us
Filters
Showing results (521-530 of 560) with videos related to
Page
of 56
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2024
CONTACT-01: A Randomized Phase III Trial of Atezolizumab + Cabozantinib Versus Docetaxel for Metastatic Non-Small Cell Lung Cancer After a Checkpoint Inhibitor and Chemotherapy
Joel Neal, Nick Pavlakis, Sang-We Kim, et al.
Nature Communications
|
June 26, 2021
Molecular determinants of response to PD-L1 blockade across tumor types
Romain Banchereau, Ning Leng, Oliver Zill, et al.
Reproductive Medicine and Biology
|
January 19, 2026
Prevalence and Characteristics of Women With Polycystic Ovary Syndrome and Isolated Diagnostic Feature: A Nationwide Cross-Sectional Survey
Md Shahed-Morshed, Mashfiqul Hasan, Tania Tofail, et al.
Urology
|
July 19, 2023
Predicting Limited Survival Following Inguinal Lymph Node Dissection in Penile Cancer: Should We Revisit the Goals of Care?
Lee A Hugar, Taylor C Peak, Mahrukh Naqvi, et al.
Annals of Surgical Oncology
|
October 14, 2021
Talimogene Laherparepvec (T-VEC) for the Treatment of Advanced Locoregional Melanoma After Failure of Immunotherapy: An International Multi-Institutional Experience
Michael J Carr, James Sun, Danielle DePalo, et al.
European Urology
|
March 8, 2021
Efficacy and Safety of Atezolizumab Plus Bevacizumab Following Disease Progression on Atezolizumab or Sunitinib Monotherapy in Patients with Metastatic Renal Cell Carcinoma in IMmotion150: A Randomized Phase 2 Clinical Trial
Thomas Powles, Michael B Atkins, Bernard Escudier, et al.
Science Translational Medicine
|
May 15, 2015
Anti-CD20/CD3 T cell-dependent bispecific antibody for the treatment of B cell malignancies
Liping L Sun, Diego Ellerman, Mary Mathieu, et al.
BMJ Open
|
August 8, 2018
Protocol for a scoping review to support development of a CONSORT extension for randomised controlled trials using cohorts and routinely collected health data
Linda Kwakkenbos, Mahrukh Imran, Kimberly A McCord, et al.
Annals of Surgical Oncology
|
March 27, 2019
Long-Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter Analysis
John T Miura, Hidde M Kroon, Georgia M Beasley, et al.
BMJ (Clinical Research Ed.)
|
April 30, 2021
CONSORT extension for the reporting of randomised controlled trials conducted using cohorts and routinely collected data (CONSORT-ROUTINE): checklist with explanation and elaboration
Linda Kwakkenbos, Mahrukh Imran, Stephen J McCall, et al.
Page
of 56
Search research articles
Search
Showing results (521-530 of 560) with videos related to
Sort By:
Page
of 56
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2024
CONTACT-01: A Randomized Phase III Trial of Atezolizumab + Cabozantinib Versus Docetaxel for Metastatic Non-Small Cell Lung Cancer After a Checkpoint Inhibitor and Chemotherapy
Joel Neal, Nick Pavlakis, Sang-We Kim, et al.
Nature Communications
|
June 26, 2021
Molecular determinants of response to PD-L1 blockade across tumor types
Romain Banchereau, Ning Leng, Oliver Zill, et al.
Reproductive Medicine and Biology
|
January 19, 2026
Prevalence and Characteristics of Women With Polycystic Ovary Syndrome and Isolated Diagnostic Feature: A Nationwide Cross-Sectional Survey
Md Shahed-Morshed, Mashfiqul Hasan, Tania Tofail, et al.
Urology
|
July 19, 2023
Predicting Limited Survival Following Inguinal Lymph Node Dissection in Penile Cancer: Should We Revisit the Goals of Care?
Lee A Hugar, Taylor C Peak, Mahrukh Naqvi, et al.
Annals of Surgical Oncology
|
October 14, 2021
Talimogene Laherparepvec (T-VEC) for the Treatment of Advanced Locoregional Melanoma After Failure of Immunotherapy: An International Multi-Institutional Experience
Michael J Carr, James Sun, Danielle DePalo, et al.
European Urology
|
March 8, 2021
Efficacy and Safety of Atezolizumab Plus Bevacizumab Following Disease Progression on Atezolizumab or Sunitinib Monotherapy in Patients with Metastatic Renal Cell Carcinoma in IMmotion150: A Randomized Phase 2 Clinical Trial
Thomas Powles, Michael B Atkins, Bernard Escudier, et al.
Science Translational Medicine
|
May 15, 2015
Anti-CD20/CD3 T cell-dependent bispecific antibody for the treatment of B cell malignancies
Liping L Sun, Diego Ellerman, Mary Mathieu, et al.
BMJ Open
|
August 8, 2018
Protocol for a scoping review to support development of a CONSORT extension for randomised controlled trials using cohorts and routinely collected health data
Linda Kwakkenbos, Mahrukh Imran, Kimberly A McCord, et al.
Annals of Surgical Oncology
|
March 27, 2019
Long-Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter Analysis
John T Miura, Hidde M Kroon, Georgia M Beasley, et al.
BMJ (Clinical Research Ed.)
|
April 30, 2021
CONSORT extension for the reporting of randomised controlled trials conducted using cohorts and routinely collected data (CONSORT-ROUTINE): checklist with explanation and elaboration
Linda Kwakkenbos, Mahrukh Imran, Stephen J McCall, et al.
Page
of 56